References
- Hunzelmann N, Scharffeter-Kochanek K, Hager C, Krieg T, Management of localized scleroderma. Sem Cutan Med Surg (1998) 17: 34–40.
- Kerscher M, Meurer M, Sander C et al, PUVA-bath photochemotherapy for localized scleroderma. Arch Dermatol (1996) 132: 1280–2.
- Karrer S, Abels C, Landthaler M, Szeimies RM, Topical photodynamic therapy for localized scleroderma. Acta Derm Venereol (Stockh) (2000) 80: 26–7.
- Boelsma E, Pavel S, Ponec M, Effects of calcitriol on fibroblasts derived from skin of scleroderma patients. Dermatology (1995) 191: 226–33.
- Bottomley WW, Jutley J, Wood EJ, Goodfield MDJ, The effect of calcipotriol on lesional fibroblasts from patients with active morphoea. Acta Derm Venerol (Stockh) (1995) 75: 364–6.
- Cunningham BB, Landells IDR, Langman C et al, Topical calcipotriene for morphea/linear scleroderma. J Am Acad Dermatol (1998) 39: 211–5.
- Humbert PG, Dupond JL, Rochefort A et al, Localized scleroderma - response to 1,25-dihydroxyvitamin D3. Clin Exp Dermatol (1990) 15: 396–8.
- Humbert P, Dupond JL, Agache P et al, Treatment of scleroderma with oral 1,25-dihydroxyvitamin D3: evaluation of skin involvement using non-invasive techniques. Acta Derm Venerol (Stockh) (1993) 73: 449–51.
- Hulshof MM, Pavel S, Breedveld FC et al, Oral calcitriol as a new therapeutic modality for generalized morphea. Arch Dermatol (1994) 130: 1290–3.
- Piraccini BM, Vincenzi C, Lorenzi S et al, Oral calcitriol in the treatment of scleroderma ‘‘en coup de sabre’’. J Dermatol Treat (2000) 11: 207–8.